You are reviewing medication options for a patient experiencing allergic conjunctivitis. Which class of medications would be best to consider?

Allergic conjunctivitis is an inflammatory eye condition triggered by exposure to allergens such as pollen, dust, or animal dander. It results from histamine release from mast cells in the conjunctiva, leading to itching, redness, tearing, and swelling. Effective treatment targets histamine-mediated symptoms to provide rapid relief and reduce ocular inflammation. Antihistamine-based eye drops are commonly used as first-line therapy for symptom control. Rationale: A. Ophthalmic alpha adrenergic agonists primarily act as vasoconstrictors to reduce ocular redness but do not address the underlying histamine-mediated inflammatory response in allergic conjunctivitis. While they may temporarily decrease redness, they do not relieve itching, which is the hallmark symptom. Overuse can also lead to rebound redness, making them less suitable as primary therapy. B. Ophthalmic macrolides such as antibiotic eye drops are used to treat bacterial infections like bacterial conjunctivitis, not allergic conditions. Allergic conjunctivitis is not caused by bacteria, so antimicrobial therapy does not address the underlying pathophysiology. Using antibiotics unnecessarily may contribute to resistance and does not relieve histamine-driven symptoms. C. Ophthalmic carbonic anhydrase inhibitors are used to reduce intraocular pressure in conditions such as glaucoma by decreasing aqueous humor production. They have no role in treating allergic conjunctivitis because they do not target histamine release or inflammatory pathways involved in allergy. Their mechanism is unrelated to allergic ocular symptoms. D. Ophthalmic H1 antagonists are the most appropriate class because they directly block histamine receptors responsible for itching, redness, and tearing in allergic conjunctivitis. These agents provide rapid symptom relief by preventing histamine from binding to conjunctival receptors. They are often used alone or in combination with mast cell stabilizers for both acute relief and prevention of recurrent symptoms.